These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2545793)

  • 1. Value of ER-D5 immunocytochemical determination in routine tissue sections of human breast cancer.
    Giani C; Campani D; De Negri F; Perpoli F; Capotorti E; Squartini F; Pinchera A
    Int J Biol Markers; 1989; 4(1):1-7. PubMed ID: 2545793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of potentially suitable fixatives for immunoperoxidase staining of estrogen receptors in imprints and frozen sections of breast carcinoma.
    Raymond WA; Leong AS
    Pathology; 1988 Oct; 20(4):320-5. PubMed ID: 2853860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-estradiol immunoperoxidase labeling of nuclei, not cytoplasm, in paraffin sections, determines estrogen receptor status of breast cancer.
    O'Keane JC; Okon E; Moroz K; Burke B; Sheahan K; O'Brien MJ
    Am J Surg Pathol; 1990 Feb; 14(2):121-7. PubMed ID: 2154140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunocytochemical staining of estrogen receptor in conventional formalin-fixed paraffin sections in human breast cancer].
    Kawakami S; Kojima O; Uehara Y; Takahashi T
    Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):102-7. PubMed ID: 2468075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen receptor staining of paraffin-embedded breast carcinomas following short fixation in formalin: a comparison with cytosolic and frozen section receptor analyses.
    Raymond WA; Leong AS
    J Pathol; 1990 Apr; 160(4):295-303. PubMed ID: 2162939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whither cytosolic estrogen receptor assays? A comparison of commercially available kits for estrogen receptor assay.
    Bilous AM; Tyler JP; Toppila M; Milliken J
    Pathology; 1987 Jul; 19(3):223-8. PubMed ID: 3324022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical assay for estrogen receptor with monoclonal antibody D753P gamma in routinely processed formaldehyde-fixed breast tissue. Comparison with frozen section assay and with monoclonal antibody H222.
    Miller RT; Hapke MR; Greene GL
    Cancer; 1993 Jun; 71(11):3541-6. PubMed ID: 8490902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imprint immunocytochemistry of estrogen receptors in breast carcinoma.
    Moriya T; Manabe T; Tsukayama C; Yamashita K; Ipponsugi S; Sonoo H; Senoo T
    Jpn J Clin Oncol; 1990 Jun; 20(2):159-63. PubMed ID: 2164614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical assessment of estrogen and progesterone receptors in stored imprints and cryostat sections of breast carcinomas.
    DeRosa CM; Ozzello L; Habif DV; Konrath JG; Greene GL
    Ann Surg; 1989 Aug; 210(2):224-8. PubMed ID: 2547346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated immunohistochemical estrogen receptor in fixed embedded breast carcinomas. Comparison with manual immunohistochemistry on frozen tissues.
    Cohen C; Unger ER; Sgoutas D; Bradley N; Chenggis M
    Am J Clin Pathol; 1989 Nov; 92(5):669-72. PubMed ID: 2816820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cytoplasmatic estrogen receptor related protein (ER-D5 Ag) in breast cancer.
    Nardelli GB; Marson S; Crocco M; Coronella ML
    Eur J Gynaecol Oncol; 1989; 10(2):141-3. PubMed ID: 2721521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining of estrogen receptor in paraffin sections of breast carcinomas using monoclonal antibody D75P3 gamma: effects of fixation.
    De Rosa CM; Ozzello L; Greene GL; Habif DV
    Am J Surg Pathol; 1987 Dec; 11(12):943-50. PubMed ID: 2825550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma.
    Gong Y; Symmans WF; Krishnamurthy S; Patel S; Sneige N
    Cancer; 2004 Feb; 102(1):34-40. PubMed ID: 14968416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of an estrogen receptor-related phosphoprotein with histopathological features in breast cancer.
    Tomasino RM; Daniele E; Nuara R; Morello V; Salvato M; Florena AM
    Int J Biol Markers; 1989; 4(2):95-102. PubMed ID: 2549126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of cytoplasmic and nuclear estrogen receptors. A histochemical study on human mammary cancer and rabbit uterus.
    Lee SH
    Cancer; 1989 Oct; 64(7):1461-6. PubMed ID: 2550122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections.
    Shimada A; Kimura S; Abe K; Nagasaki K; Adachi I; Yamaguchi K; Suzuki M; Nakajima T; Miller LS
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4803-7. PubMed ID: 3860824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen receptor assay by ER-D5 immunocytochemistry fails to correlate with ligand-binding assay in breast cancer.
    van der Walt LA; Phillips JI; Afrika DJ
    S Afr Med J; 1988 Dec; 74(11):581-3. PubMed ID: 3194808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor immunocytochemical assay on cytologic material from primary and metastatic breast cancer.
    Greenberg ML; Earl MJ; Bilous AM; Ekberg H; Milliken J; Pacey NF
    Pathology; 1989 Apr; 21(2):93-9. PubMed ID: 2812883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between ER-EIA and ER-D5-Ag-IRMA in breast cancer.
    Alessi A; Crocco M; Sandri A; Petrillo MR
    Eur J Gynaecol Oncol; 1989; 10(1):61-2. PubMed ID: 2645142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
    Alberts SR; Ingle JN; Roche PR; Cha SS; Wold LE; Farr GH; Krook JE; Wieand HS
    Cancer; 1996 Aug; 78(4):764-72. PubMed ID: 8756370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.